Liminatus Pharma, Inc. (LIMN)
0.1866
+0.01
(+6.63%)
USD |
NASDAQ |
Apr 06, 16:00
0.1895
0.00 (0.00%)
After-Hours: 20:00
Liminatus Pharma EPS Diluted (Quarterly) : -0.3018 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CDT Equity, Inc. | -329.03 |
| LENZ Therapeutics, Inc. | -1.155 |
| Oruka Therapeutics, Inc. | -0.5436 |
| Maze Therapeutics, Inc. | -0.7007 |
| MapLight Therapeutics, Inc. | -1.807 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.169M |
| Total Expenses (Quarterly) | 8.169M |
| Enterprise Value | 8.445M |
| Earnings Yield | -180.2% |
| Normalized Earnings Yield | -92.05 |